Approved Study Database

Ref. No. Scientific Title Principal investigator
2016.133 Robust T1rho magnetic resonance imaging of liver on human subjects Prof. CHEN Weitian
陈蔚天
2020.571 Robotic Technology and Digital Health Applications in Primary Care Prof. WONG Samuel
2020.019 Robotic Radical Perineal Prostatectomy for Localized Prostate Cancer: A Feasibility Study Dr. YEE Chi Hang
余知行
2023.135 ROBI Project: Community-Based Holistic Service Supporting At-Risk Families with Age 0-2 Children Prof. YIP Virginia Choy Yin
葉彩燕
2021.210 RNA N6-methyladenosine methyltransferase-like 3 (METTL3) is a potential therapeutic target for immunotherapy in colorectal cancer Dr. CHEN Huarong
2023.022 RNA N6-Methyladenosine Demethylase AlkB Homolog 5 (ALKBH5) promotes stemness and chemoresistance in colorectal cancer: mechanism and novel therapeutic approaches Prof. YU Jun
于君
2022.026 RNA N6-Methyladenosine (m6A) Methyltransferase METTL3 facilitates non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLDHCC) via a m6A-cholesterol axis to repress T-cell function Prof. YU Jun
于君
2022.108 RNA m6A甲基化识别蛋白YTHDF1在调控结直肠癌免疫微环境中的作用及机制研究 (Elucidating the role and mechanism of RNA m6A reader YTHDF1 in regulating the immune microenvironment of colorectal cancer) Prof. YU Jun
于君
2023.114 RNA m6A去甲基化酶ALKBH5对结直肠癌化疗疗效的影响及作用机制 (Targeting RNA m6A eraser ALKBH5 boosts the efficacy of chemotherapy in colorectal cancer) Prof. YU Jun
于君
2020.684 RNA Demethylase AlkB Homolog 5 (ALKBH5) drives immune suppression in colorectal cancer via epitranscriptome regulation of AXIN2-WNT-DKK1 axis Prof. YU Jun
于君
2015.153 Rivastigmine for cognitive impairment after aneurysmal subarachnoid hemorrhage: a randomized placebo-controlled clinical trial. Prof. WONG George Kwok Chu
2020.113 Risks of serious infections and opportunistic infections in patients on immunosuppressive and biological modifier therapies – a population-based study Prof. MAK Wing Yan
麥詠欣
2012.168 Risk-benefit evaluation of the introduction of a rotavirus vaccine into the Hong Kong Child Immunisation Programme Professor Nelson Edmund Anthony
2017.591 Risk stratification of TIA or minor stroke using artificial neural network Dr. LENG Xinyi
2007.354 Risk Stratification in Inter-Facility Transport of Upper Gastrointestinal Bleeding Patients LEUNG Sasi Choi Patrick
2015.391 Risk stratification for hypertension patients incorporating both clinical and automatic retinal image analysis outcomes  Prof. ZEE Benny Chung Ying
徐仲鍈
2006.175 Risk Stratification for Active Pulmonary Tuberculosis Using Whole Blood Interferon-y Assay COCKRAM CS
2021.525 Risk screening for prodromal Parkinson’s disease in elderly using smartphone Dr. HUANG Bei
2009.043 Risk Predictors of Vascular Complication after Diagnostic Cardiac Cathetherization and Percutaneous Coronary Interventions CHENG Kit Yan
2013.262 Risk perception in paranoid delusions and generalised anxiety disorder Ms. CHAN Gloria Hoi Kei
2007.275 Risk of Tuberculosis in Patients with Rheumatoid Arthritis in Hong Kong TAM Lai Shan
2020.707 Risk of self-harm after the diagnosis of psychiatric disorders in Hong Kong: a retrospective study Prof. TANG Wai Kwong
鄧偉光
2020.527 Risk of radiation-induced ocular complications after radiotherapy for nasopharyngeal carcinoma: A retrospective cross sectional cohort study Dr. CHAN Ching Yan
2017.335 Risk of post colonoscopic polypectomy bleeding in patients on anti-platelets and anti-coagulant – case control study Dr. LAU Louis Ho Shing
2024.373 Risk of non-arteritic anterior ischemic optic neuropathy with glucagon-like peptide-1 receptor agonist – a territory-wide study Dr. Ip Yiu Ming Bonaventure
2012.570 Risk of Intracerebral Haemorrhage in Patients Taking Oral Anticoagulants for Atrial Fibrillation with Cerebral Microbleeds. A Prospective Study in Warfarin. (IPAAC-Warfarin Study) Dr. SOO Yannie Oi Yan
2014.419 Risk of Intracerebral Haemorrhage in Patients Taking Oral Anticoagulants for Atrial Fibrillation with Cerebral Microbleeds. A Prospective Study in Warfarin - Phase II Study. (IPAAC-Warfarin Phase II Study) Dr. SOO Yannie Oi Yan
2014.359 Risk of Intracerebral Haemorrhage in Patients Taking Oral Anticoagulants for Atrial Fibrillation with Cerebral Microbleeds. A Prospective Study in Novel Oral Anticoagulants. (IPAAC-NOAC Study) Dr. SOO Yannie O.Y.
2017.214 Risk of hepatocellular carcinoma in patients with chronic hepatitis B achieved complete viral suppression – role of on-treatment hepatitis B surface/core-related antigen (HBsAg/HBcrAg) levels Dr. WONG Grace Lai Hung
黃麗虹
2020.079 Risk of hepatitis flare in patients with previous hepatitis B virus exposure amongst patients on immunosuppressive and biological modifier therapies Prof. MAK Wing Yan
麥詠欣
2016.479 Risk of gastrointestinal bleeding in patients with non-ST elevation myocardial infarction and treated with double anti-platelet and anti-coagulation therapies: a retrospective analysis Dr. TSANG Chiu Chung
曾招聰
2021.487 Risk of bleeding complications in patients on oral anticoagulants: a population-based study Dr LAU Louis Ho Shing
2017.386 Risk of anti-tuberculous drug-induced hepatotoxicity in patients with chronic hepatitis B infection: impact of antiviral therapy Dr. LUI Grace Chung Yan
雷頌恩
2012.216 Risk of advanced colorectal neoplasm in patients with non-alcoholic fatty liver disease CHAN Lik Yuen Henry
2011.090 Risk index for screening subclinical brian lesions in communitydwelling elderly persons in Hong Kong Prof. MOK Vincent Chung Tong
2008.341 Risk Factors of Community Associated Methicillin Resistant Stapylococcus Aureus Infection in Hong Kong Dr. Lai Wai Man
2006.189 Risk Factors of Breast Cancer in Chinese: Genetic, Pathology and Epidemiology Study TANG Leung Sang Nelson
2010.412 Risk factors of ankle ligamentos sprain and hamstring strain in Hong Kong peofessional soccer players Prof Fong Daniel Tik-Pui
2017.050 Risk factors for treatment failure in patients with cellulitis in an emergency medicine ward in Hong Kong: a retrospective cohort study Dr. LEUNG Michael Hou Jiu
梁顥耀
2019.145 Risk factors for treatment failure and recurrence after metronidazole and vancomycin treatment for Clostridium difficile infection in Hong Kong Dr. TSANG Chi Wo
2022.366 Risk factors for susceptibility, severity and prognosis of inflammatory myopathies Dr. SO Ho
2024.032 Risk factors for severe intraventricular hemorrhage in preterm infants born less than 29 weeks of gestation: a single center retrospective analysis Dr. YUNG Vivian Queenie
Vivian Yung
2006.019 Risk Factors for Oral Mucositis in Pediatrics Patients Undergoing Chemotherapy: A Matched Case-control Study CHENG Kin Fong Karis
2006.154 Risk Factors for HCV Infection in Linxian, Henan, A Community with High Prevalence of HCV Infection ZHANG Ming Dong
2017.643 Risk factors for a loss of extension after anterior cruciate ligament reconstruction Miss IEONG Ho Ieng
2023.665 Risk Factors Associated with Transplant-Related Mortality and Survival in Paediatric Population undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study Mr. NG Ho Man
2014.707 Risk factors associated with glucocorticoid-induced adverse effects in ambulatory children (aged 0-18) with autoimmune disease: A retrospective cross-sectional study Miss Ng Kin Yin
2014.587 Risk Estimation Following Infarction Noninvasive Evaluation - ICD efficacy Study Dr. CHAN Joseph Yat Sun
2020.093 Risk estimates for coronary heart disease and stroke subtypes using retinal images Miss QU Yimin
曲翌敏
2016.511 Risk Assessment for Diabetic Retinopathy Using Novel Retinal Imaging: Personalized Medicine for Diabetes Dr. CHEUNG Carol Yim Lui

Page 50 of 254.